Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25088-57-7

Post Buying Request

25088-57-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25088-57-7 Usage

General Description

(Z,Z)-di-9-octadecenyl phosphonate is a chemical compound belonging to the class of phosphonates. It is a lipid-based molecule with two long hydrophobic chains that are derived from oleic acid, a common unsaturated fatty acid. (Z,Z)-di-9-octadecenyl phosphonate is commonly used as a surfactant and emulsifying agent in various industrial applications. It is known for its ability to stabilize and disperse insoluble substances in aqueous solutions. Additionally, (Z,Z)-di-9-octadecenyl phosphonate has been studied for its potential applications in drug delivery systems and as a component in biomedical materials due to its ability to interact with cell membranes and improve the solubility of hydrophobic drugs. Overall, (Z,Z)-di-9-octadecenyl phosphonate has versatile properties that make it a valuable ingredient in various fields of science and industry.

Check Digit Verification of cas no

The CAS Registry Mumber 25088-57-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,0,8 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 25088-57:
(7*2)+(6*5)+(5*0)+(4*8)+(3*8)+(2*5)+(1*7)=117
117 % 10 = 7
So 25088-57-7 is a valid CAS Registry Number.

25088-57-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name bis[(Z)-octadec-9-enoxy]-oxophosphanium

1.2 Other means of identification

Product number -
Other names diolelyl hydrogen phosphonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25088-57-7 SDS

25088-57-7Downstream Products

25088-57-7Relevant articles and documents

Key determinants of siRNA delivery mediated by unique pH-responsive lipid-based liposomes

Sako, Mariko,Song, Furan,Okamoto, Ayaka,Koide, Hiroyuki,Dewa, Takehisa,Oku, Naoto,Asai, Tomohiro

, (2019)

Lipid-based nanoparticles, a potential nonviral vector due to their good biocompatibility and biodegradability, have been extensively developed for the delivery of small interfering RNA (siRNA). We designed a unique pH-responsive lipid derivative, a dioleylphosphate-diethylenetriamine conjugate (DOP-DETA). DOP-DETA consists of a pH-responsive triamine and unsaturated fatty acids that accelerate membrane fusion. Our results showed that DOP-DETA-based liposomes (DL) efficiently delivered siRNA into the cytoplasm and induced RNA interference even at a low siRNA concentration. The knockdown efficiency of DL depended on the molar ratio of total DL lipids to siRNA. When siRNA was formulated with a sufficient amount of DL, it was efficiently taken up by cells and induced effective gene silencing. Time-lapse imaging showed that siRNA transfected with DL was rapidly internalized into the cells and uniformly dispersed in the cytoplasm within a few minites. The results also showed that DL induced sufficient change in surface charge to allow it to interact with the cell membrane and to allow for rapid endosomal escape. Uptake pathway and time-lapse imaging studies revealed that siRNA was delivered by DL into the cytoplasm, possibly through both macropinocytosis and membrane fusion. The present results emphasize that the modulation of surface charge on nanoparticles is crucial for each siRNA delivery process. Our results also suggest that DL is a potentially useful vector for inducing gene silencing with low-doses of siRNA.

NANOPARTICLE PEG MODIFICATION WITH H-PHOSPHONATES

-

Paragraph 0131; 0132; 0133;, (2013/03/28)

The present invention provides phosphonate conjugates and methods of preparing the phosphonate conjugates so as to allow, for example, improved methods and compounds for modifying the surface of a nanoparticle to increase in vivo circulation times and targeted delivery performance.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25088-57-7